RKDA
Arcadia Biosciences, Inc.NASDAQBasic Materials$1.30-3.85%ClosedMarket Cap: $1.8M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.43
P/S
0.37
EV/EBITDA
-0.47
DCF Value
$-45.67
FCF Yield
-266.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.2%
Operating Margin
-51.4%
Net Margin
-48.1%
ROE
-40.6%
ROA
-35.7%
ROIC
-55.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $901.0K | 21.4% | $-1.4M | $-1.3M | $-0.98 | — |
| FY 2025 | $4.9M | 36.2% | $-10.0M | $-2.3M | $-1.71 | — |
| Q3 2025 | $1.3M | 32.1% | $-1.2M | $856.0K | $0.62 | — |
| Q2 2025 | $1.5M | 43.4% | $-501.0K | $-4.5M | $-3.26 | — |
| Q1 2025 | $1.2M | 43.2% | $530.0K | $2.6M | $1.90 | — |
| Q4 2024 | $1.2M | 32.0% | $-2.3M | $-4.1M | $-1.18 | — |
| FY 2024 | $5.0M | 41.3% | $-3.6M | $-7.0M | $-5.16 | — |
| Q3 2024 | $1.5M | 32.9% | $-1.8M | $-1.6M | $-1.18 | — |
| Q2 2024 | $1.3M | 51.5% | $2.0M | $1.1M | $0.78 | — |
| Q1 2024 | $987.0K | 52.3% | $-1.6M | $-2.4M | $-1.78 | — |
| Q4 2023 | $1.2M | 42.7% | $-3.4M | $-2.9M | $-2.22 | — |
| FY 2023 | $4.5M | 51.2% | $-6.1M | $-14.0M | $-11.30 | — |